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ABSTRACT
We uncovered a role for nucleoli and PML-bodies as phase-separated protein quality control organelles
that compartmentalize protein quality control factors and misfolded proteins for their efficient clear-
ance. Failure to dispose misfolded proteins converts nucleoli and PML-bodies into a solid state that
immobilizes ubiquitin, limiting its recycling for genome integrity maintenance.
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Eukaryotic cells are constantly exposed to a multitude of stres-
sors that challenge their proteome, thus threatening cell func-
tionality. Maintenance of nuclear protein homeostasis (or
proteostasis) is particularly important to preserve genome integ-
rity. Imbalances in nuclear proteostasis are linked to age-related
neurodegenerative diseases, many of which are characterized by
nuclear protein aggregates and genomic instability .1 Although
nuclear protein aggregation induces mutagenesis and DNA
damage, we do not understand how these processes are linked
on the molecular level. Moreover, we still have a limited under-
standing of how the nucleus copes with protein misfolding.
Maintenance of the nuclear proteome requires the transport
of proteins through nuclear pores. This transport process is
highly selective, although proteins with low molecular weight
(< 40 kDa) can passively diffuse through these pores. In addition
to regulating protein and RNA transport between the nucleus
and cytoplasm, nuclear pores and the nuclear envelope also
protect the nuclear proteome from misfolded proteins. The
main source of misfolded proteins in mammalian cells are
newly synthesized polypeptides that failed to reach their native
state and defective ribosomal products (DRiPs), which cannot
properly fold due to errors occurring during DNA replication
(DNA mutations), transcription (damaged mRNAs) or transla-
tion (amino acid misincorporation, premature translation ter-
mination or pervasive translation outside of protein-coding
regions) .2,3 Upon their synthesis in the cytoplasm, DRiPs are
recognized and bound by the chaperones Heat Shock Protein
Family A (HSP70) and Valosin Containing Protein (VCP),
which assist their targeting for proteasome-mediated degrada-
tion or autophagy .1,4 Failure to clear DRiPs, due to HSP70 and
VCP inhibition, leads to proteostasis imbalances and the aber-
rant accumulation of DRiPs inside ribonucleoprotein (RNP)
granules .5 We recently showed that the accumulation of mis-
folded proteins in cytoplasmic membraneless organelles such as
stress-inducible RNP granules causes their conversion into an
aggregate-like state with pathological implications .6
In Mediani et al., we now show for the first time that
DRiPs not only affect membraneless organelles in the cyto-
plasm, but also in the nucleus. We provide evidence that
a fraction of low molecular weight DRiPs can diffuse into the
nucleus and accumulate in two nuclear membraneless com-
partments: nucleoli and Promyelocytic Leukemia Protein
(PML) bodies. Nucleoli and PML-bodies function, respec-
tively, as constitutive and stress-responsive overflow com-
partments for DRiPs, which are then cleared by chaperones
and proteasomes. The finding that defective proteins such as
DRiPs are transiently stored inside the nucleolus of normally
growing mammalian cells was surprising and highlights two
important concepts: first, nuclear proteostasis is constantly
challenged by the influx of low molecular weight misfolding-
prone proteins; second, nuclear quality control compart-
ments exert a buffering function by capturing DRiPs and
preventing their aberrant interactions with other essential
nuclear components (Figure 1).
The accumulation of proteins inside nucleoli is not unprece-
dented. Previous studies identified nucleolar subcompartments
that accumulate proteins upon stress conditions: the amyloid-
body (A-body) and the nucleolar aggresome (NoA) .7,8 In addi-
tion, the granular subcompartment of the nucleolus was recently
identified as a storage site for later refolding or disposal of
misfolded proteins, including thermolabile firefly luciferase .9
Our study demonstrates that these nucleolar subcompartments
are the same structure, referred to as Nucleolar A-bodies
(NoABs), and establishes a new function for the nucleolus as
protein quality control (PQC) compartment. The peptides that
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are stored inside NoABs seem to be heterogeneous: besides
DRiPs, the misfolded model substrates firefly luciferase and
VHL, as well as arginine-rich dipeptide repeats, which are asso-
ciated with Amyotrophic Lateral Sclerosis (ALS), were transi-
ently retained within NoABs .9 These misfolded proteins are
cleared with the assistance of HSP70 and proteasomes. But
what happens if DRiPs cannot be cleared from nucleoli? We
found that if not efficiently removed by chaperones and protea-
somes, DRiPs trigger amyloidogenesis of nucleoli, with potential
consequences on nucleolar functions. Thus, irreversible NoAB
aggregation may represent an important mechanism contribut-
ing to aging and disease-associated toxicity.
Some proteotoxic stress conditions, such as temperature
upshift or proteasome inhibition, cause a strong increase in
the total amount of DRiPs. When the DRiP concentration
reaches a critical threshold in the nucleoplasm, PML-bodies
are induced and act as stress-responsive compartments that
concentrate DRiPs together with ubiquitin, proteasomes
and chaperones (Figure 1). Thus, PML-bodies are stress-
adaptable compartments that fulfill different functions in
resting and stressed cells: in resting cells, PML-bodies func-
tion as post-translational and epigenetic control sites,
whereas in stressed cells they are PQC and sorting sites
for the efficient clearance of DRiPs. Similar to NoABs,
failure to clear DRiPs from PML-bodies, due to chaperone
impairment, convert them into an amyloid-like solid state
that immobilizes ubiquitin and proteasomes (Figure 1).
Which are the functional consequences of sequestering
large amounts of quality control factors in quality control
compartments? Ubiquitin is not only required for PQC, but
also to repair damaged DNA, making the nuclear ubiquitin
levels a limiting factor under certain conditions. Moreover,
proliferation of mammalian cells often goes along with some
degree of DNA replication failure, leading to spontaneous
DNA lesions. Considering that the repair of these lesions
requires ubiquitination, 10 we investigated whether there is
a trade-off between nuclear proteostasis and genome integrity.
Indeed, we found that nuclear proteostasis and DNA repair
compete for a limiting pool of ubiquitin. Importantly, upon
proteotoxic stress conditions, ubiquitin is primarily used to
label DRiPs for clearance, to the detriment of its use for DNA
repair mediated by Tumor Protein P53 Binding Protein 1
(also known as 53BP1). Based on these findings, we conclude
that NoAB and PML-body formation represents a protective
stress response aimed at prioritizing the restoration of nuclear
proteostasis. However, this comes at a price, because pro-
longed immobilization of ubiquitin and proteasomes at PML-
bodies endangers genome stability and cell health. This sug-
gests that severe stress conditions and chronic diseases that
impair PQC function, such as polyglutamine diseases and
ALS, also jeopardize genome stability and cell viability.
Together, these findings make a strong case for further
investigations aimed at elucidating the quality control func-
tions of nucleoli and PML-bodies and how dysregulation of
Figure 1. Role of nucleoli and PML-bodies in nuclear proteostasis. A fraction of low molecular weight DRiPs escapes the cytoplasmic protein quality control system
and enters the nucleus. DRiPs are transiently stored in nucleolar subcompartments (NoABs) for later disposal by chaperones and proteasomes. Upon proteotoxic
stress conditions, such as heat shock, and proteasome inhibition, a fraction of DRiPs is transiently compartmentalized at PML-bodies, which act as stress-responsive
overflow compartments. Along with DRiPs, PML-bodies recruit ubiquitin, chaperones and proteasomes to promote efficient DRiP degradation. Failure to clear DRiPs
from NoABs and PML-bodies leads to their solidification and immobilizes ubiquitin and proteasomes. This, in turn, depletes the pool of free ubiquitin to the
detriment of the ubiquitin-dependent labeling of DNA damaged sites.
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these compartments affects genome integrity and contributes
to human aging and disease. Recent studies highlighted that
a substantial fraction of nascent peptides is destroyed within
minutes after their synthesis by proteasomes. Some of these
peptides are generated from upstream open-reading frames3
and globally these peptides are referred to as the “dark pro-
teome”, being their sequence and structure unknown. This
“dark proteome”, located in the cytoplasm and the nucleus,
would challenge nuclear proteostasis by potentially competing
with mutated and unstable proteins for folding and clearance.
Its identification will uncover important molecular targets,
whose handling may offer therapeutic perspectives for the
treatment of protein conformation diseases. On the other
hand, combined treatments with drugs that impair nucleoli
and PML-body quality control functions may sensitize and
efficiently kill cancer cells, which are characterized by high
translation rates and genome instability.
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